User profiles for Carol CH Kwok

Carol Kwok

Consultant, Hospital Authority, Hong Kong
Verified email at ha.org.hk
Cited by 1249

Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: a factorial study

…, ACK Cheng, PM Wu, MWM Law, CCH Kwok… - Journal of clinical …, 2004 - ascopubs.org
Carol CH Kwok … Dora LW Kwong, Jonathan ST Sham, Gordon KH Au, Daniel TT Chua,
Philip WK Kwong, Ashley CK Cheng, PM Wu, Martin WM Law, Carol CH Kwok, CC Yau, KY Wan, …

Effect of radioactive iodine therapy on cytokine production in Graves' disease: transient increases in interleukin-4 (IL-4), IL-6, IL-10, and tumor necrosis factor-α, with …

BM Jones, CCH Kwok, AWC Kung - The Journal of Clinical …, 1999 - academic.oup.com
Spontaneous and mitogen-stimulated production of interleukin-4 (IL-4), IL-6, IL-10, IL-12,
interferon-γ (IFNγ), and tumor necrosis factor-α were evaluated by enzyme-linked immunospot …

Quality of life associated with nausea and vomiting from anthracycline-based chemotherapy: a pooled data analysis from three prospective trials

…, E Pang, M Cheung, V Chan, CCH Kwok… - The …, 2021 - academic.oup.com
Background There is limited work on the impact of chemotherapy-induced nausea and
vomiting (CINV) on quality of life (QoL) in adriamycin-cyclophosphamide (AC)–treated patients …

Forced unfolding modulated by disulfide bonds in the Ig domains of a cell adhesion molecule

P Carl, CH Kwok, G Manderson… - Proceedings of the …, 2001 - National Acad Sciences
Cell adhesion molecules (CAMs) mediate cell attachment and stress transfer through extracellular
domains. Here we forcibly unfold the Ig domains of a prototypical Ig superfamily CAM …

[PDF][PDF] Preoperative considerations and benefits of neoadjuvant chemotherapy: insights from a 12-year review of the Hong Kong breast cancer registry

YHY Chan, CCH Kwok, DMS Tse, HM Lee, PY Tam… - Hong Kong Med J, 2023 - hkmj.org
Introduction: Neoadjuvant chemotherapy (NAC) was initially used for locally advanced or
inoperable breast cancers. Its extension to early disease has facilitated breast-conserving …

Patterns of care and survival of Chinese glioblastoma patients in the temozolomide era: A Hong Kong population-level analysis over a 14-year period

…, MWY Lee, R Yeung, CCH Kwok… - Neuro-Oncology …, 2023 - academic.oup.com
Background The aim of this study is to address the paucity of epidemiological data regarding
the characteristics, treatment patterns and survival outcomes of Chinese glioblastoma …

Comparative efficacy of three 5-HT3 antagonists (granisetron, ondansetron, and tropisetron) plus dexamethasone for the prevention of cisplatin-induced acute emesis …

…, JST Sham, DLW Kwong, CCH Kwok… - American journal of …, 2000 - journals.lww.com
The purpose of this study was to compare the antiemetic efficacy of three 5-HT3 antagonists
(granisetron, ondansetron, tropisetron) plus dexamethasone for the prevention of acute …

[HTML][HTML] The impact of the Oncotype DX breast cancer assay on treatment decisions for women with estrogen receptor-positive, node-negative breast carcinoma in …

…, C Yoshizawa, IS Soong, WH Kwan, CCH Kwok… - Clinical breast …, 2016 - Elsevier
Background The Oncotype DX Breast Cancer Assay is validated to assess risk of distant
recurrence and likelihood of chemotherapy (CT) benefit in estrogen receptor-positive ESBC in …

NEPA efficacy and tolerability during (neo) adjuvant breast cancer chemotherapy with cyclophosphamide and doxorubicin

W Yeo, TKH Lau, CCH Kwok, KT Lai… - BMJ supportive & …, 2022 - spcare.bmj.com
Objectives This is a prospective study evaluating NEPA in patients with breast cancer (the
NEPA group), who received (neo)adjuvant AC chemotherapy (consisting of doxorubicin 60 mg/…

Effects of primary granulocyte-colony stimulating factor prophylaxis on neutropenic toxicity and chemotherapy dose delivery in Chinese patients with breast cancer …

CCH Kwok, WH Wong, LL Chan… - Hong Kong Medical …, 2022 - search.proquest.com
Introduction: This study was performed to examine the effects of primary granulocyte-colony
stimulating factor (G-CSF) prophylaxis on neutropenic toxicity, chemotherapy delivery, and …